TECAN LIMITED
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Fabricated Structural Metal, Miscellaneous Structural Metal Work, Fabricated Metal Products, Not Elsewhere Classified, Manufacturing Industries, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about TECAN LIMITED
Live alerts from global media, monitored by Business Radar
2025-04-30 (labbulletin.com)
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours
BioSkryb Genomics and Tecan Group has introduced a high-throughput single-cell workflow, combining BioSkryb's 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan.
Read more
2025-02-25 (labmate-online.com)
Simple extraction of THC metabolites from urine with a single plate
Tecan has developed an innovative sample preparation method using its AC Extraction Plate, featuring Tecan Immobilized Coating Extraction (TICE™) technology. Click to read more...
Read more
2025-02-25 (labmate-online.com)
Simple extraction of THC metabolites from urine with a single plate
Tecan has developed an innovative sample preparation method using its AC Extraction Plate, featuring Tecan Immobilized Coating Extraction (TICE™) technology. Click to read more...
Read more
2024-10-19 (selectscience.net)
Build the interconnected lab of the future through digitalization
In this article, Tecan experts share how to empower your lab by digitalizing the instruments and labware used in your lab workflows
Read more
2024-02-20 (selectscience.net)
The MALDI Biotyper system
Bruker introduces the MALDI Biotyper System designed to address key challenges in clinical microbiology
Read more
2024-02-19 (selectscience.net)
Multiplex analysis of Predictive Oncology's 3D tumor models
Tecan highlights the use of their Spark Cyto reader as a powerful instrument for analyzing 3D cell cultures
Read more
2024-02-02 (selectscience.net)
Continuous mRNA manufacturing to boost vaccine production
New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technology
Read more
2024-02-02 (selectscience.net)
Continuous mRNA manufacturing to boost vaccine production
New mRNA-based therapies and vaccines could be developed more quickly and cheaply thanks to new manufacturing technology
Read more
2021-11-18 (nature.com)
Mapping protein carboxymethylation sites provides insights into their role in proteostasis and cell proliferation | Communications
Posttranslational mechanisms play a key role in modifying the abundance and function of cellular proteins. Among these, modification by advanced glycation end products has been shown to accumulate during aging and age-associated diseases but specific protein targets and functional consequences remain largely unexplored. Here, we devise a proteomic strategy to identify sites of carboxymethyllysine modification, one of the most abundant advanced glycation end products. We identify over 1000 sites of protein carboxymethylation in mouse and primary human cells treated with the glycating agent glyoxal. By using quantitative proteomics, we find that protein glycation triggers a proteotoxic response and indirectly affects the protein degradation machinery. In primary endothelial cells, we show that glyoxal induces cell cycle perturbation and that carboxymethyllysine modification reduces acetylation of tubulins and impairs microtubule dynamics.
Read more
2021-07-13 (biomedcentral.com)
In vivo and in vitro efficacy of crocin against Echinococcus multilocularis | Parasites & Vectors | Full Text
Alveolar echinococcosis (AE) is a fatal zoonosis caused by the larvae of Echinococcus multilocularis. However, current chemotherapy treatment options are based on benzimidazoles [albendazole (ABZ) and mebendazole], which have limited efficacy. Therefore, novel drugs are necessary for the treatment of this disease. The anthelmintic effects of crocin were tested on E. multilocularis metacestodes, germinal cells and protoscoleces in vitro. Human foreskin fibroblasts (HFFs) and Reuber rat hepatoma (RH) cells were used to assess cytotoxicity. The in vivo efficacy of crocin was investigated in mice following secondary infection with E. multilocularis. Furthermore, collagen deposition and degradation in host tissues around the metacestodes were evaluated. In vitro, crocin had a median effective concentration of 11.36 μM against cultured E. multilocularis metacestodes, while it reduced germinal cell viability at a median inhibitory concentration of 10.05 μM. Crocin was less toxic to HFFs and RH mammalian cell lines
Read more
2015-12-02 (cambridgenetwork.co.uk)
Tecan helps Repsol to drive the fuels of the future
Jose Miguel Seoane, a researcher in the biotechnology department, explained: “The investigation of new biological applications involves screening large numbers of mutants of different micro-organisms, enabling the best performing candidates to be selected for further studies.
Read more
(informa.com)
Tecan introduces robotic sample processor
Tecan, a group of companies headquartered in Switzerland, launched a new generation of laboratory robots at Medica last month. The Genesis series includes a robotic sample processor( RSP) which enhances Tecan 's traditional core business with new software and instruments and a robotic microplate
Read more